UnitedHealth’s big bet on the business of going to the doctor

Hello,

Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and this week in healthcare news:

If you’re new to this newsletter, sign up here. Tips, comments? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let’s get to it…


Coming up today, a group of CDC advisors will discuss their recommendations for what comes next for Johnson & Johnson’s COVID-19 vaccine.

Insider’s Hilary Brueck spoke to five of the experts voting on the fate of the vaccine.

They said they’re eager to end the pause and may ask that a warning be added for women.


Wyatt Decker, CEO of OptumHeath
OptumHealth CEO Wyatt Decker

Building a $100 billion business

UnitedHealth is on its way to building a $100 billion business around going to the doctor.

Shelby Livingston spoke with Dr. Wyatt Decker, the CEO of OptumHealth, who’s in charge of building that unit, about how virtual care will play a role, and what comes next.

Growing the business would cement UnitedHealth even further as a massive player in delivering medical care.

Here’s how>>

The CEO of UnitedHealth’s sprawling health-clinic business shared how transforming the way doctors get paid will help it notch $100 billion in revenue


Walmart Health
A Walmart Health clinic with counseling, labs, optometry, primary care, dental, and hearing services.

Key healthcare departures at Walmart

Blake Dodge and Shelby have been keeping tabs on Walmart’s healthcare strategy after reporting in February that the retail giant’s clinic strategy was in flux.

This week, they took a look at all the leaders leaders involved in the original plans for the clinics who have departed, including the upcoming departure of Walmart’s chief medical officer.

We mapped out who left>>

Walmart’s healthcare leaders are exiting the company as it taps the brakes on an ambitious clinic rollout


Moderna vaccine
Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida, on August 13, 2020.

New science could help solve biotech’s thorniest challenges

This week, our reporters also spent some time looking at the potential future of biotech.

Andrew Dunn pinpointed 5 takeaways from Walter Isaacson’s best-selling book on Jennifer Doudna, the pioneering scientist who won a Nobel Prize for discovering CRISPR – including what ethical questions now face the cutting-edge gene-editing tool.

Meanwhile, Patricia Kelly Yeo took a closer look at the plans Moderna’s laid out to develop an HIV vaccine.

After the success of Moderna’s COVID-19 vaccine, it’s possible the biotech could chart a new path toward a vaccine that’s eluded researches for decades.

There’s a long road ahead>>

Moderna’s mRNA technology could help in the decades-long search for an HIV vaccine


Finally, here’s what’s happening with healthcare startups this week:


– Lydia

Read the original article on Business Insider